N. Avci Et Al. , "Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer," JOURNAL OF BUON , vol.20, no.1, pp.45-49, 2015
Avci, N. Et Al. 2015. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. JOURNAL OF BUON , vol.20, no.1 , 45-49.
Avci, N., DELİGÖNÜL, A., TOLUNAY, Ş., ÇUBUKÇU, E., Olmez, O. F., Ulas, A., ... Hartavi, M.(2015). Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. JOURNAL OF BUON , vol.20, no.1, 45-49.
Avci, Nilufer Et Al. "Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer," JOURNAL OF BUON , vol.20, no.1, 45-49, 2015
Avci, Nilufer Et Al. "Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer." JOURNAL OF BUON , vol.20, no.1, pp.45-49, 2015
Avci, N. Et Al. (2015) . "Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer." JOURNAL OF BUON , vol.20, no.1, pp.45-49.
@article{article, author={Nilufer Avci Et Al. }, title={Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer}, journal={JOURNAL OF BUON}, year=2015, pages={45-49} }